ACADIA PHARMACEUTICALS INC — Form D
ACADIA PHARMACEUTICALS INC of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-01-02. The offering totals $86.4M, of which $86.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-01-02
- Form: D
- Accession: 0001549257-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $86.4M
- Amount sold: $86.4M
- Investors: 29
- Date of first sale: 2012-12-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-189257
Issuer
- Name: ACADIA PHARMACEUTICALS INC
- CIK: 0001070494
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA, 92121
- Phone: 858-558-2871
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| MICHAEL T BORER | Director | SAN DIEGO, CA |
| LAURA A BREGE | Director | SAN DIEGO, CA |
| MARY ANN T GRAY | Director | SAN DIEGO, CA |
| Uli Hacksell | Director | WAKE FOREST, NC |
| LESLIE L IVERSEN | Director | SAN DIEGO, CA |
| LESTER J KAPLAN | Director | SAN DIEGO, CA |
| TORSTEN T RASMUSSEN | Director | SAN DIEGO, CA |
| WILLIAM M WELLS | Director | SAN DIEGO, CA |
| THOMAS H AASEN | Executive Officer | SAN DIEGO, CA |
| GLENN F BAITY | Executive Officer | SAN DIEGO, CA |
| Uli Hacksell | Executive Officer | WAKE FOREST, NC |
| ROGER G MILLS | Executive Officer | SAN DIEGO, CA |
Other filings by this issuer (1)
More